RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @ELS_Cardiology: Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy https://t.co/gw0EblJT2P…
Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy https://t.co/gw0EblJT2P #SoMe #medtwitter #MedEd @JACCJournals https://t.co/sA3NsLAESZ
Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy https://t.co/eVvbJb0hBX
Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy https://t.co/hAAj44UYb0 #SoMe #medtwitter #MedEd https://t.co/lTc0SxfsnH
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @HanCardiomd: Clinicians can use a wide variety of clinical assessments, biomarkers, and imaging modalities to inform prognostic assessm…
RT @HanCardiomd: Clinicians can use a wide variety of clinical assessments, biomarkers, and imaging modalities to inform prognostic assessm…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
Clinicians can use a wide variety of clinical assessments, biomarkers, and imaging modalities to inform prognostic assessments for patients newly diagnosed with ATTR-CM @escardio @DrRyanPDaly @nossikoff @_kayaesra_ @radcliffeCARDIO @purviparwani @HFA_Presi
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
Prognostic factors of ATTR-CM are critically important with #tafamidis $200k+/yr --> Reason to consider Vyndaqel 20 mg vs. 80 mg as well
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
@premsoman123
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @TRassafMD: Think of amyloid cardiomyopathy..cardiologists often miss. Proud of our team #PeterLuedike and #MariaPapathanasiou who build…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @TRassafMD: Think of amyloid cardiomyopathy..cardiologists often miss. Proud of our team #PeterLuedike and #MariaPapathanasiou who build…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @TRassafMD: Think of amyloid cardiomyopathy..cardiologists often miss. Proud of our team #PeterLuedike and #MariaPapathanasiou who build…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
Think of amyloid cardiomyopathy..cardiologists often miss. Proud of our team #PeterLuedike and #MariaPapathanasiou who build up the #EssenerAmyloidoseZentrum together with our colleagues from #Neurology, #Hematology, #Radiology and #Nuklearmedicine at the
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
RT @JACCJournals: Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In thi…
Tansthyretin amyloid cardiomyopathy (ATTR-CM) has emerged as an increasingly identified etiology of #heartfailure. In this #JACCCardioOnc Primer, Drs. @_adevore, @DukeHFDoc and @DukeHealth colleagues present best practices for ATTR-CM management. https://t
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
RT @gonzaeperez: EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis…
EVALUACIÓN PRONÓSTICA EN #AMILOIDOSIS TTR ✔️Buen cuadro ✔️Pero no tenemos demasiadas herramientas terapéuticas ⏩#Tafamidis y ensayos clínicos en marcha Que les parece? @jpcostabel @paomorejon @Dr_Manito @onco_cardiology #JACCCardioOnc @JACCJournals htt
RT @kentfengMD: Happy to have our review published in #JACCCardioOnc! Prognostic factors for TTR amyloid cardiomyopathy https://t.co/DkQO5E…